Belgium’s Poison Control Centre reports a steep rise in overdoses involving Ozempic and Wegovy as their popularity for weight loss grows nationwide, prompting public health warnings
With nearly half of Belgians overweight, Wegovy’s arrival ignites public discussion on obesity treatment affordability, healthcare costs, and calls for official recognition of obesity as a biological disease
In a bold move to address a critical shortage of Novo Nordisk's diabetes drug Ozempic, Belgium has temporarily banned its use as a weight loss treatment
